Table 2.
β-Lactamase | Antibacterial agent | kcat (s−1)a | Km or Ki (μM)a | kcat/Km or Ki (μM−1 s−1) |
---|---|---|---|---|
AmpC (P. aeruginosa) | cefiderocol | NHb | 214 ± 49.6c | ND |
ceftazidime | NHb | 5.3 ± 1.0c | ND | |
cefepime | NHb | 12.2 ± 0.1c | ND | |
cefalotin | 95.4 ± 9.3 | 24.5 ± 3.2 | 3.89 | |
meropenem | NHb | 1.7 ± 0.4c | ND | |
P99 (E. cloacae) | cefiderocol | NHb | >1700d | ND |
ceftazidime | (2.7 ± 0.49) × 10−3 | 1.8 ± 0.099c | 0.0015 | |
cefepime | 0.69 ± 0.028 | 210 ± 21 | 0.0033 | |
cefalotin | 86 ± 1.5 | 5.8 ± 0.44 | 15 | |
meropenem | NHb | 0.26 ± 0.0096c | ND |
NH, no hydrolysis detected; ND, not determined (because no hydrolysis was detected).
Each kcat and Km or Ki value is the mean ± SD of three different measurements.
Hydrolysis was too weak to determine the kcat value.
Ki values were obtained using 100 μM cefalotin.
This value was the detection limit of the spectrophotometer and no hydrolysis was observed at this concentration.